Narrowband UVB phototherapy

DEVICE5 trials

Sponsors

Medical University of Graz, Henry Ford Health System, Psoriasis Treatment Center of Central New Jersey, Women's College Hospital, Minia University

Conditions

Atopic DermatitisEczemaPhototherapyPsoriasisSkin DiseasesVitiligo

Unknown Phase

Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.

CompletedNCT00407342

Medical University of GrazPsoriasis

Start: 2004-02-29End: 2004-09-30Updated: 2009-09-30

Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

WithdrawnNCT01818154

Henry Ford Health SystemPhototherapy

Start: 2012-05-31End: 2013-12-31Updated: 2022-03-02

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

RecruitingNCT03392337

Psoriasis Treatment Center of Central New JerseyPsoriasis

Start: 2017-11-07End: 2020-01-01Target: 30Updated: 2019-01-30

BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort

TerminatedNCT04818138

Women's College HospitalAtopic Dermatitis, Eczema, Skin Diseases

Start: 2021-09-27End: 2025-06-05Updated: 2026-07-21

Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo

Active, not recruitingNCT07532330

Minia UniversityVitiligo

Start: 2025-08-01End: 2026-04-10Updated: 2026-04-17